\begin{thebibliography}{10}
\providecommand \doibase [0]{http://dx.doi.org/}%

\bibitem{Craig2008}
Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing
  and evaluating complex interventions: the new Medical Research Council
  guidance. {\it BMJ: British Medical Journal} 2008\string; 337.
\newblock \href {\doibase 10.1136/bmj.a1655} {doi: 10.1136/bmj.a1655}

\bibitem{Eldridge2016}
Eldridge SM, Lancaster GA, Campbell MJ, et al. Defining Feasibility and Pilot
  Studies in Preparation for Randomised Controlled Trials: Development of a
  Conceptual Framework. {\it {PLOS} {ONE}} 2016\string; 11(3)\string: e0150205.
\newblock \href {\doibase 10.1371/journal.pone.0150205} {doi:
  10.1371/journal.pone.0150205}

\bibitem{NIHR2017}
{National Institute for Health Research} . Research for Patient Benefit (RfPB)
  Programme Guidance on Applying for Feasibility Studies. 2017.

\bibitem{Eldridge2016a}
Eldridge SM, Chan CL, Campbell MJ, et al. {CONSORT} 2010~{s}tatement: extension
  to randomised pilot and feasibility trials. {\it {BMJ}} 2016\string: i5239.
\newblock \href {\doibase 10.1136/bmj.i5239} {doi: 10.1136/bmj.i5239}

\bibitem{Avery2017}
Avery KNL, Williamson PR, Gamble C, et al. Informing efficient randomised
  controlled trials: exploration of challenges in developing progression
  criteria for internal pilot studies. {\it {BMJ} Open} 2017\string;
  7(2)\string: e013537.
\newblock \href {\doibase 10.1136/bmjopen-2016-013537} {doi:
  10.1136/bmjopen-2016-013537}

\bibitem{Hampson2017}
Hampson LV, Williamson PR, Wilby MJ, Jaki T. A framework for prospectively
  defining progression rules for internal pilot studies monitoring recruitment.
  {\it Statistical Methods in Medical Research} 2017\string; 0(0)\string:
  0962280217708906.
\newblock PMID: 28589752\href {\doibase 10.1177/0962280217708906} {doi:
  10.1177/0962280217708906}

\bibitem{Browne1995}
Browne RH. On the use of a pilot sample for sample size determination. {\it
  Statistics in Medicine} 1995\string; 14(17)\string: 1933--1940.
\newblock \href {\doibase 10.1002/sim.4780141709} {doi: 10.1002/sim.4780141709}

\bibitem{Julious2005}
Julious SA. Sample size of 12 per group rule of thumb for a pilot study. {\it
  Pharmaceutical Statistics} 2005\string; 4(4)\string: 287--291.
\newblock \href {\doibase 10.1002/pst.185} {doi: 10.1002/pst.185}

\bibitem{Sim2012}
Sim J, Lewis M. The size of a pilot study for a clinical trial should be
  calculated in relation to considerations of precision and efficiency. {\it
  Journal of Clinical Epidemiology} 2012\string; 65(3)\string: 301--308.
\newblock \href {\doibase 10.1016/j.jclinepi.2011.07.011} {doi:
  10.1016/j.jclinepi.2011.07.011}

\bibitem{Teare2014}
Teare M, Dimairo M, Shephard N, Hayman A, Whitehead A, Walters S. Sample size
  requirements to estimate key design parameters from external pilot randomised
  controlled trials: a simulation study. {\it Trials} 2014\string;
  15(1)\string: 264.
\newblock \href {\doibase 10.1186/1745-6215-15-264} {doi:
  10.1186/1745-6215-15-264}

\bibitem{Eldridge2015}
Eldridge SM, Costelloe CE, Kahan BC, Lancaster GA, Kerry SM. How big should the
  pilot study for my cluster randomised trial be?. {\it Statistical Methods in
  Medical Research} 2015.
\newblock \href {\doibase 10.1177/0962280215588242} {doi:
  10.1177/0962280215588242}

\bibitem{Whitehead2015}
Whitehead AL, Julious SA, Cooper CL, Campbell MJ. Estimating the sample size
  for a pilot randomised trial to minimise the overall trial sample size for
  the external pilot and main trial for a continuous outcome variable. {\it
  Statistical Methods in Medical Research} 2015.
\newblock \href {\doibase 10.1177/0962280215588241} {doi:
  10.1177/0962280215588241}

\bibitem{Viechtbauer2015}
Viechtbauer W, Smits L, Kotz D, et al. A simple formula for the calculation of
  sample size in pilot studies. {\it Journal of Clinical Epidemiology}
  2015\string; 68(11)\string: 1375--1379.
\newblock \href {\doibase 10.1016/j.jclinepi.2015.04.014} {doi:
  10.1016/j.jclinepi.2015.04.014}

\bibitem{Cooper2018}
Cooper CL, Whitehead A, Pottrill E, Julious SA, Walters SJ. Are pilot trials
  useful for predicting randomisation and attrition rates in definitive
  studies: A review of publicly funded trials. {\it Clinical Trials}
  2018\string; 0(0)\string: 1740774517752113.
\newblock PMID: 29361833\href {\doibase 10.1177/1740774517752113} {doi:
  10.1177/1740774517752113}

\bibitem{Wilson2015}
Wilson DT, Walwyn RE, Brown J, Farrin AJ, Brown SR. Statistical challenges in
  assessing potential efficacy of complex interventions in pilot or feasibility
  studies. {\it Statistical Methods in Medical Research} 2015\string;
  25(3)\string: 997--1009.
\newblock \href {\doibase 10.1177/0962280215589507} {doi:
  10.1177/0962280215589507}

\bibitem{OHagan2005}
O'Hagan A, Stevens JW, Campbell MJ. Assurance in clinical trial design. {\it
  Pharmaceutical Statistics} 2005\string; 4(3)\string: 187--201.
\newblock \href {\doibase 10.1002/pst.175} {doi: 10.1002/pst.175}

\bibitem{Crisp2018}
Crisp A, Miller S, Thompson D, Best N. Practical experiences of adopting
  assurance as a quantitative framework to support decision making in drug
  development. {\it Pharmaceutical Statistics} 2018\string; 0(0).
\newblock \href {\doibase 10.1002/pst.1856} {doi: 10.1002/pst.1856}

\bibitem{Wang2002}
Wang F, Gelfand AE. A Simulation-Based Approach to Bayesian Sample Size
  Determination for Performance under a Given Model and for Separating Models.
  {\it Statistical Science} 2002\string; 17(2)\string: pp. 193-208.

\bibitem{Walley2015}
Walley RJ, Smith CL, Gale JD, Woodward P. Advantages of a wholly Bayesian
  approach to assessing efficacy in early drug development: a case study. {\it
  Pharmaceutical Statistics} 2015\string; 14(3)\string: 205--215.
\newblock \href {\doibase 10.1002/pst.1675} {doi: 10.1002/pst.1675}

\bibitem{French2000}
French S, Insua DR. {\it Statistical Decision Theory}.
\newblock No.~9 in Kendall's Library of StatisticsOxford University Press .
\newblock 2000.

\bibitem{Keeney1976}
Keeney RL, Raiffa H. {\it Decisions with multiple objectives: preferences and
  value tradeoffs}.
\newblock John Wiley \& Sons .
\newblock 1976.

\bibitem{Forster2017}
Forster A, , Airlie J, et al. Research Exploring Physical Activity in Care
  Homes ({REACH}): study protocol for a randomised controlled trial. {\it
  Trials} 2017\string; 18(1).
\newblock \href {\doibase 10.1186/s13063-017-1921-8} {doi:
  10.1186/s13063-017-1921-8}

\bibitem{Spiegelhalter2001}
Spiegelhalter DJ. Bayesian methods for cluster randomized trials with
  continuous responses. {\it Statistics in Medicine} 2001\string; 20(3)\string:
  435--452.
\newblock \href {\doibase
  10.1002/1097-0258(20010215)20:3<435::AID-SIM804>3.0.CO;2-E} {doi:
  10.1002/1097-0258(20010215)20:3<435::AID-SIM804>3.0.CO;2-E}

\bibitem{rstan}
{Stan Development Team} . {RStan}: the {R} interface to {Stan}. 2016.
\newblock R package version 2.14.1.

\bibitem{Jung2004}
Jung SH, Lee T, Kim KM, George SL. Admissible two-stage designs for phase {II}
  cancer clinical trials. {\it Statistics in Medicine} 2004\string;
  23(4)\string: 561--569.
\newblock \href {\doibase 10.1002/sim.1600} {doi: 10.1002/sim.1600}

\bibitem{Mander2012}
Mander AP, Wason JM, Sweeting MJ, Thompson SG. Admissible two-stage designs for
  phase {II} cancer clinical trials that incorporate the expected sample size
  under the alternative hypothesis. {\it Pharmaceutical Statistics}
  2012\string; 11(2)\string: 91--96.
\newblock \href {\doibase 10.1002/pst.501} {doi: 10.1002/pst.501}

\bibitem{Bacchetti2010}
Bacchetti P. Current sample size conventions: Flaws, harms, and alternatives.
  {\it BMC Medicine} 2010\string; 8(1)\string: 17.
\newblock \href {\doibase 10.1186/1741-7015-8-17} {doi: 10.1186/1741-7015-8-17}

\bibitem{Dallow2018}
Dallow N, Best N, Montague TH. Better decision making in drug development
  through adoption of formal prior elicitation. {\it Pharmaceutical Statistics}
  2018\string; 0(0).
\newblock \href {\doibase 10.1002/pst.1854} {doi: 10.1002/pst.1854}

\bibitem{OHagan2006a}
O'Hagan A, Buck CE, Daneshkhah A, et al. {\it Uncertain Judgements: Eliciting
  Experts' Probabilities}.
\newblock John Wiley and Sons .
\newblock 2006.

\bibitem{Sutton2007}
Sutton AJ, Cooper NJ, Jones DR, Lambert PC, Thompson JR, Abrams KR.
  Evidence-based sample size calculations based upon updated meta-analysis.
  {\it Statistics in Medicine} 2007\string; 26(12)\string: 2479--2500.
\newblock \href {\doibase 10.1002/sim.2704} {doi: 10.1002/sim.2704}

\bibitem{Strong2014}
Strong M, Oakley JE, Brennan A. Estimating Multiparameter Partial Expected
  Value of Perfect Information from a Probabilistic Sensitivity Analysis
  Sample. {\it Medical Decision Making} 2014\string; 34(3)\string: 311--326.
\newblock \href {\doibase 10.1177/0272989x13505910} {doi:
  10.1177/0272989x13505910}

\bibitem{Strong2015}
Strong M, Oakley JE, Brennan A, Breeze P. Estimating the expected value of
  sample information using the probabilistic sensitivity analysis sample: a
  fast, nonparametric regression-based method. {\it Medical Decision Making}
  2015\string; 35(5)\string: 570--583.
\newblock \href {\doibase 10.1177/0272989x15575286} {doi:
  10.1177/0272989x15575286}

\bibitem{Jones2001}
Jones DR. A Taxonomy of Global Optimization Methods Based on Response Surfaces.
  {\it Journal of Global Optimization} 2001\string; 21(4)\string: 345-383.
\newblock \href {\doibase 10.1023/A:1012771025575} {doi:
  10.1023/A:1012771025575}

\bibitem{Roustant2012}
Roustant O, Ginsbourger D, Deville Y. {DiceKriging}, {DiceOptim}: Two {R}
  Packages for the Analysis of Computer Experiments by Kriging-Based
  Metamodeling and Optimization. {\it Journal of Statistical Software}
  2012\string; 51(1)\string: 1--55.

\bibitem{Lancaster2004}
Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies:
  recommendations for good practice. {\it Journal of Evaluation in Clinical
  Practice} 2004\string; 10(2)\string: 307--312.
\newblock \href {\doibase 10.1111/j..2002.384.doc.x} {doi:
  10.1111/j..2002.384.doc.x}

\bibitem{Lindley1997}
Lindley DV. The choice of sample size. {\it Journal of the Royal Statistical
  Society: Series D (The Statistician)} 1997\string; 46(2)\string: 129--138.
\newblock \href {\doibase 10.1111/1467-9884.00068} {doi:
  10.1111/1467-9884.00068}

\bibitem{Joseph1997a}
Joseph L, Wolfson DB. Interval-based versus decision theoretic criteria for the
  choice of sample size. {\it Journal of the Royal Statistical Society: Series
  D (The Statistician)} 1997\string; 46(2)\string: 145--149.
\newblock \href {\doibase 10.1111/1467-9884.00070} {doi:
  10.1111/1467-9884.00070}

\bibitem{Bacchetti2008}
Bacchetti P, McCulloch CE, Segal MR. Simple, Defensible Sample Sizes Based on
  Cost Efficiency. {\it Biometrics} 2008\string; 64(2)\string: 577--585.
\newblock \href {\doibase 10.1111/j.1541-0420.2008.01004\_1.x} {doi:
  10.1111/j.1541-0420.2008.01004\_1.x}

\bibitem{Whitehead2008}
Whitehead J, Vald{\'{e}}s-M{\'{a}}rquez E, Johnson P, Graham G. Bayesian sample
  size for exploratory clinical trials incorporating historical data. {\it
  Statistics in Medicine} 2008\string; 27(13)\string: 2307--2327.
\newblock \href {\doibase 10.1002/sim.3140} {doi: 10.1002/sim.3140}

\bibitem{Stallard2012}
Stallard N. Optimal sample sizes for phase {II} clinical trials and pilot
  studies. {\it Statistics in Medicine} 2012\string; 31(11-12)\string:
  1031--1042.
\newblock \href {\doibase 10.1002/sim.4357} {doi: 10.1002/sim.4357}

\bibitem{Wason2013}
Wason JMS, Jaki T, Stallard N. Planning multi-arm screening studies within the
  context of a drug developmentâ€‰program. {\it Statistics in Medicine}
  2013\string; 32(20)\string: 3424--3435.
\newblock \href {\doibase 10.1002/sim.5787} {doi: 10.1002/sim.5787}

\bibitem{Goette2015}
Götte H, Schüler A, Kirchner M, Kieser M. Sample size planning for phase {II}
  trials based on success probabilities for phase {III}. {\it Pharmaceutical
  Statistics} 2015\string; 14(6)\string: 515--524.
\newblock \href {\doibase 10.1002/pst.1717} {doi: 10.1002/pst.1717}

\bibitem{Kirchner2015}
Kirchner M, Kieser M, Götte H, Schüler A. Utility-based optimization of phase
  {II}/{III} programs. {\it Statist. Med.} 2015\string; 35(2)\string: 305--316.
\newblock \href {\doibase 10.1002/sim.6624} {doi: 10.1002/sim.6624}

\end{thebibliography}
